Author: digi

Bulk Sterile Product Manufacturing: Hold Times, Bioburden and Mixing Controls Comprehensive Step-by-Step Guide to Bulk Sterile Product Manufacturing Hold Times, Bioburden, and Mixing Controls Manufacturing sterile pharmaceutical products requires precise control of multiple critical process parameters to ensure patient safety and product efficacy. This is particularly relevant for sterile dosage forms such as parenterals, inhalation…

Read More “Bulk Sterile Product Manufacturing: Hold Times, Bioburden and Mixing Controls” »

Aseptic Compounding vs Industrial Manufacturing: GMP Boundaries Aseptic Compounding vs Industrial Manufacturing: Defining GMP Boundaries Across Dosage Forms Good Manufacturing Practice (GMP) compliance serves as the foundation for ensuring pharmaceutical product quality, safety, and efficacy. However, the interpretation and application of GMP principles vary considerably when comparing aseptic compounding environments with large-scale industrial manufacturing operations….

Read More “Aseptic Compounding vs Industrial Manufacturing: GMP Boundaries” »

Hospital-Filled Syringes and Bags: GMP vs Pharmacy Compounding Rules Comprehensive Step-by-Step GMP Guide: Hospital-Filled Syringes and Bags vs Pharmacy Compounding The preparation of hospital-filled syringes and infusion bags occupies a critical intersection between formal pharmaceutical manufacturing and pharmacy compounding. Given the complexity and risks associated with sterile dosage forms such as parenteral products, understanding the…

Read More “Hospital-Filled Syringes and Bags: GMP vs Pharmacy Compounding Rules” »

Modified-Release Capsules: GMP Controls for Pellets, Multiparticulates and Coatings Modified-Release Capsules: Ensuring GMP Compliance for Pellets, Multiparticulates, and Coatings Modified-release capsules represent a critical dosage form within contemporary pharmaceutical solid oral products. Their ability to deliver active pharmaceutical ingredients (APIs) over controlled time frames enhances therapeutic outcomes, patient compliance, and safety profiles. However, such dosage…

Read More “Modified-Release Capsules: GMP Controls for Pellets, Multiparticulates and Coatings” »

GMP for Oral Nutraceutical and OTC Products in Pharmaceutical Facilities Practical GMP Guide for Oral Nutraceutical and OTC Dosage Forms in Pharmaceutical Manufacturing Good Manufacturing Practice (GMP) compliance remains the cornerstone of pharmaceutical quality assurance and regulatory adherence for manufacturers of oral nutraceuticals and over-the-counter (OTC) products. This step-by-step tutorial provides a detailed roadmap for…

Read More “GMP for Oral Nutraceutical and OTC Products in Pharmaceutical Facilities” »

Combination Products: Drug–Device GMP at the Drug Product Interface Ensuring Effective GMP Compliance for Combination Products at the Drug Product Interface The manufacture of combination products, which integrate pharmaceutical drug components with medical devices, presents intricate challenges for Good Manufacturing Practice (GMP) compliance. These products often span multiple dosage forms including solid oral tablets and…

Read More “Combination Products: Drug–Device GMP at the Drug Product Interface” »

GMP for Pen Injector and Auto-Injector Combination Products Step-by-Step GMP Guide for Pen Injector and Auto-Injector Combination Products Combination products, especially pen injectors and auto-injectors, are increasingly prevalent in pharmaceutical therapy. These devices integrate a drug product component with a delivery device, thus requiring stringent compliance with Good Manufacturing Practice (GMP) tailored to their unique…

Read More “GMP for Pen Injector and Auto-Injector Combination Products” »

Wearable Injectors and On-Body Delivery Systems: New GMP Challenges Understanding and Managing GMP Challenges in Wearable Injectors and On-Body Delivery Systems The pharmaceutical industry is experiencing the convergence of innovative drug delivery technologies with established pharmaceutical Good Manufacturing Practice (GMP) frameworks. Among these innovations, wearable injectors and on-body delivery systems represent a new frontier. These…

Read More “Wearable Injectors and On-Body Delivery Systems: New GMP Challenges” »

GMP for Osmotic Pump Tablets and Advanced Oral Delivery Systems Pharmaceutical GMP for Osmotic Pump Tablets and Advanced Oral Delivery Systems: A Step-by-Step Guide The advancement of oral delivery systems beyond traditional immediate-release tablets and capsules has necessitated tailored Good Manufacturing Practice (GMP) approaches. Osmotic pump tablets, a prominent form of advanced solid oral dosage…

Read More “GMP for Osmotic Pump Tablets and Advanced Oral Delivery Systems” »